Suchergebnisse - "Knox, Jennifer"

PubPharm (359)

1

A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2024

von Santoro, A. | Assenat, E. | Yau, T. | +12

2

CALGB 80802 (Alliance) : Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

enthalten in: Cancer research communications | 2024

von Abou-Alfa, G. | Geyer, S. | Nixon, A. | +18

3

Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma

enthalten in: Molecular cancer therapeutics | 2024

von Lee, C. | O'Kane, G. | Mason, W. | +8

4

Minimally invasive determination of PDAC subtype and therapy-induced subtype switch by means of circulating cell-free RNA

enthalten in: ResearchSquare.com | 2024

von Lueong, S. | Metzenmacher, M. | Trajkovic-Arsic, M. | +13

5

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Llovet, J. | Kudo, M. | Merle, P. | +123

ErratumIn: Lancet Oncol. 2024 Apr;25(4):e137. - PMID 38547896

6

First impressions : A prospective evaluation of patient-physician concordance and satisfaction following the initial medical oncology consultation

enthalten in: Cancer medicine | 2023

von Bach, Y. | Panov, E. | Espin-Garcia, O. | +18

7

A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors

enthalten in: Endocrine-related cancer | 2023

von Abuzakhm, S. | Sukrithan, V. | Fruth, B. | +13

8

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma : Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial

enthalten in: Liver cancer | 2023

von Merle, P. | Kudo, M. | Edeline, J. | +17

9

BRAFΔβ3-αC in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability

enthalten in: Science advances | 2023

von Lauinger, M. | Christen, D. | Klar, R. | +23

10

hENT1 as a Predictive Biomarker in PDAC-Response

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Perera, S. | Jang, G. | Grant, R. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]